Elizabeth Blackburn: Ordering Cancer Cells to Curl Up and Die

An enzyme vital to life could be pure poison to cancer cells, says the molecular and cell biologist

By Lindsay Lyon

Posted: June 30, 2009

Elizabeth Blackburn, Molecular and Cell Biologist, UC-San Francisco

Elizabeth Blackburn, Molecular and Cell Biologist, UC-San Francisco

Tetrahymena, the one-celled organism we know as pond scum, intrigued molecular biologist Elizabeth Blackburn decades ago. Its single cell divides endlessly, seemingly immortal. Blackburn, 60, suspected that an enzyme keeps the organism's genetic material from eroding, as it does in other living things. She was right—and it works the same in humans. Now telomerase, the enzyme she codiscovered, is emerging as a key link to aging, susceptibility to certain diseases, and cancer.

Telomerase makes and replenishes telomeres, tiny units of DNA. They are protective caps like shoestring tips on the ends of chromosomes that house our genetic makeup. The length of the telomeres dictates cellular life span. As they shrink when a cell divides, so does the life of the cell. In tetrahymena, constant production of telomerase keeps the telomeres intact and the cells from dying. But the enzyme level in humans isn't high enough to confer pond-scumlike immortality, says Blackburn, a molecular and cell biologist at the University of California, San Francisco.

The ability of telomerase to renew cells has a "dark side," says Blackburn: The enzyme is perfect for fueling uncontrolled division of cancer cells. But that suggested to Blackburn that she could exploit cancer cells' already high telomerase levels and engineer mutant gene variations into the enzyme to poison the cells' telomeres. "It's a great way of killing cancer cells," she says. "They just curl up their toes and die." We're nowhere near a magic drug yet, she cautions—the approach is still too preliminary to be in human trials. But since telomerase is involved in roughly 90 percent of human cancers, she sees therapeutic potential.

What particularly fascinates Blackburn these days is the possibility of changing telomerase levels to slow the deterioration of our telomeres. A low-fat diet, regular exercise, stress reduction, and other lifestyle changes helped men with early prostate cancer boost their telomerase, she and others reported last year. She and her team previously found that chronic stress lowered telomerase and shortened telomeres in a small group of women.

It's rumored that Blackburn's research is of Nobel Prize caliber, but she refuses to speculate about that or any other form of public recognition. What she likes to mull is the implication of her findings on everyday life. That includes her own. When she is stressed, or tempted to skip a workout, sometimes she scolds herself: "Damn, my telomeres will be shortened."

Irresponsibly Inaccurate

"We're nowhere near a magic drug yet, she cautions—the approach is still too preliminary to be in human trials"

How can she say this and how can Ms. Lyon report it without any mention of, much less some kind of attempt at a rational distinction from the ongoing Phase I/II trials of Geron Corp.'s GRN163L telomerase inhibitor across a broad spectrum of cancers as well as completed Phase I and ongoing Phase II human trials of a telomerase based cancer vaccines GRNVAC1 and GRNVAC2 conducted by Geron at Duke University. We are talking about work that started over 10 years ago and human trials that started as early as 5 years ago.

And we are not talking about something different or related to the mechanism Elizabeth BlackBurn refers to - we are talking about exactly the same thing. She is either attempting to establish some form of revisionist history, or claim more credit than is due her, or is so out of touch in her own field that she's saying things that might have been true 10-15 years ago.

How can it be that U.S. News and World Report doesn't verify facts and statements in the articles they print? Sloppy? Lazy? Hidden Agenda?

Come on US News and World Report, try a little Googling - and I mean very little is all it would take to put a little depth into the article and show that your organization is capable of researching a subject at least as well as any semi-literate 10 year old.

Lindsay Lyon responds:

We thank you for your interest in the subject. We consulted Dr. Blackburn on the matter and here's what she had to say:

"The writer . . . has the scientific facts wrong in his/her assertion: 'And we are not talking about something different or related to the mechanism Elizabeth Blackburn refers to--we are talking about exactly the same thing.' That assertion is incorrect. As my colleagues and I have published in peer-reviewed scientific journals, rather than inhibition of telomerase enzymatic activitiy or the use of a vaccine, the approach that was correctly referred to in the above article is to 'engineer mutant gene variations into the enzyme to poison the cells' telomeres.' As we have amply demonstrated in the published scientific literature, this approach causes effects on cancer cells that are completely distinct from either the simple inhibition the correspondent refers to or a vaccine approach. All these scientific facts are available online in the published literature. I hope this sets the factual record straight."

Dick Boland of CT @ Jul 01, 2009 09:59:03 AM

Telomere

Now I'm in a "double-bind." If stress can shorten telomere length might not "self-scolding" do so too?

L K of MA @ Jul 01, 2009 00:35:43 AM

Telomere Length

Can self-scolding shorten telomeres?

elk_l of MA @ Jul 01, 2009 00:25:48 AM

Add Your Thoughts
About You

advertisement

U.S. News Rankings & Research

Best Hospitals

See the best hospitals, and the best children's hospitals, in specialties from cancer to urology.

Best Health Plans

U.S. News and NCQA review over 700 health insurance plans in the Best Health Plan rankings.

Best Nursing Homes

The Best Nursing Homes rankings feature data on 15,000-plus homes. Search for one near you.

Diseases & Conditions

Get information on preventing, treating, and managing diseases and conditions. Centers:

advertisement

Sponsored Poll

What factor do you think is responsible for the majority of teen-driving crashes?

View Results

advertisement

Subscribe

U.S. News Digital Weekly

A weekly insider's guide to politics and policy — in a multimedia, digital format. 52 issues for $19.95!

U.S. News & World Report

6 months of U.S. News & World Report's print edition for only $15. Save up to 67% off the cover price!